ROJKJAER LISA (EVP, Chief Medical Officer) reported 1 transaction at RIGEL PHARMACEUTICALS INC
Review the transaction codes below to understand the nature of each event.
Filed: 2/12/2026ACC: 0000905148-26-000677
Officer· EVP, Chief Medical Officer
Since Feb 2026
-3.76K
Net shares
Net seller
$130.1K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
3.76K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.76K
Price / share
$34.62
Trade value
$130.10K
% of position
19.1%
2/10/2026
19.72K→15.96K
Total
Net shares
−3.76K
Net value
-$130.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/10/2026 | F · Tax Withholding | −3.76K | $34.62 | $130.10K | 19.1% | 19.72K | 15.96K |
| Total | −3.76K | -$130.10K | ||||||
Derivative Transactions0
No derivative transactions reported